Screening with fecal immunochemical tests (FITs) lowers the risk of dying from colorectal cancer (CRC), according to a study published online July 19 in JAMA Network Open. Lowering the fecal ...

Fecal immunochemical testing, which tests for human blood in a patient’s stool, is now available as a take-home test from Life Line Screening, according to a company news release. The test requires no ...

When patients of the Harris Health System have a positive FIT result, they are referred to a gastroenterologist for a colonoscopy. To help patients understand how to properly prepare for the procedure ...

Colorectal cancer (CRC) remains a major global health challenge, with early detection proving essential for effective treatment and improved patient outcomes. Fecal immunochemical testing (FIT) has ...

FIT checks for blood in the stool, which can indicate the presence of colorectal cancer or polyps. Patients collect stool ...

Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...

Please provide your email address to receive an email when new articles are posted on . Increased use of fecal immunochemical testing correlated with more colorectal cancer screenings and early-stage ...

Colorectal cancer is the third most common cancer worldwide, with over 1.9 million new cases in 2020, and is also the third most common cause of cancer-related mortality. 1 Colorectal cancer rates are ...

Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths in the United States, a troubling fact when considering that CRC is largely preventable and treatable if caught early.

In a new study aimed at identifying the best approach to promote colorectal cancer screening in adults aged 45 to 49, UCLA researchers found that simply mailing a stool-based test directly to people's ...